Lucid Ultra 128 Expert Review

The Lucid Ultra 128 is a premium behind-the-ear prescription hearing aid priced at $5,000, earning an A grade with a SoundScore of 4.21/5 in our lab testing. This places it in the top 6% of the prescription hearing aid category, ranking #3 among 35 tested devices.

Speech performance is a clear strength for this device. In our testing, speech in quiet scored a strong 4.4/5, nearly a full point above the category average of 3.43. Speech in noise measured 2.5/5—above the category average of 1.53 by 0.97 points, though only mixed in absolute terms. This suggests the Ultra 128 handles conversational clarity better than most competitors, even if challenging noise environments remain difficult.

The most notable weakness is feedback handling, which scored just 1.7/5 compared to a category average of 4.74—a substantial 3.04 points below average. This low score emerged in the tuned fit condition and represents a significant limitation for users who need higher gain settings. Music streaming also fell slightly below average at 2.3/5 versus the category's 2.61, while own-voice comfort measured 2.9/5, just above the 2.73 average.

The Lucid Ultra 128 may suit users who prioritize speech clarity and can work within its feedback limitations. However, at this price point, competitors like the Oticon Intent (4.70/5) and Phonak Sphere Infinio (4.64/5) deliver stronger overall performance. Buyers should weigh whether the Ultra 128's speech advantages offset its feedback challenges.